Skip to main content

and
  1. Article

    Open Access

    Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy

    Protein inhibitor of activated STATs (PIAS) has pleiotropic biological effects, such as protein post-translational modification, transcriptional coregulation and gene editing. It is reported that PIAS family g...

    Qiqi Zhang, Junkui Zhang, Tianyi Lan, Jiayue He in European Journal of Medical Research (2024)

  2. Article

    Open Access

    Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population

    We investigated the clinicopathological characteristics and survival of breast cancer lung metastases (BCLM) patients at initial diagnosis of metastatic breast cancer (MBC) in the Han population.

    Shaoyan Lin, Hongnan Mo, Yiqun Li, **uwen Guan, Yimeng Chen, Zi**g Wang in BMC Cancer (2021)

  3. Article

    Open Access

    Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis

    Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive disease with poor survival, and platinum-etoposide chemotherapy is indicated as the mainstay of treatment. In this study, we compared the effic...

    Shiyu Jiang, Liling Huang, Hongnan Zhen, Peijie **, **g Wang, Zhihuang Hu in BMC Cancer (2021)

  4. Article

    Open Access

    The molecular tumor burden index as a response evaluation criterion in breast cancer

    Circulating tumor DNA (ctDNA) is a potential biomarker of prognosis and therapeutic response. We conducted this study to explore the role of the molecular tumor burden index (mTBI) in ctDNA as a therapeutic re...

    Zongbi Yi, Fei Ma, Guohua Rong, Binliang Liu in Signal Transduction and Targeted Therapy (2021)

  5. No Access

    Article

    Progress in systemic therapy for triple-negative breast cancer

    Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with a heterogeneous genetic profile. Chemotherapy exhibits substantial activity in a small subset of these patients. Drug r...

    Hongnan Mo, Binghe Xu in Frontiers of Medicine (2021)

  6. Article

    Open Access

    Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway

    Breast cancer (BC) is a malignant tumor that occurs in the epithelial tissue of the breast gland. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 3 (SNHG3) has been found to promote BC cell prolifer...

    Hongnan Jiang, **aojun Li, Wei Wang, Honglin Dong in BMC Cancer (2020)